Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

December 14, 2025 updated by: Yuanlong Xie, Zhongnan Hospital

Clinical Application of Indocyanine Green Fluorescence Imaging to Assist Identification of Nerve Roots in Endoscopic Spinal Surgery

In endoscopic spinal nerve root decompression surgery, the intraoperative nerve exploration is time-consuming and critical. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Damage to nerve roots may lead to postoperative sensory retardation and motor weakness, thereby impairing the physical function of patients. A real-time auxiliary intraoperative nerve identification technology is necessary.

In this prospective, open-label, randomized, parallel controlled trial, 40 patients who undergo endoscopic spinal surgery are included. Subjects are randomly divided into control group and low, medium and high Indocyanine green(ICG) preoperative administration experimental group. Standard endoscopic spinal surgery is performed in the control group. Patients in the experimental group received an intravenous injection of ICG before surgery, and a standard endoscopic spinal surgery is performed with the use of a fluoroscopic endoscopic surgical imaging system to assist the surgeon in identifying and protecting the nerve roots.

The main objectives of this experiment are (i) to explore the safety and feasibility of ICG fluorescence imaging to assist in nerve root identification during endoscopic spinal surgery and (ii) the effectiveness of this technique for endoscopic search for nerve roots. The secondary objective is to explore the optimal ICG dosing regimen.

Study Overview

Status

Completed

Conditions

Detailed Description

With the accelerated pace of the global aging society, the prevalence of degenerative diseases is increasing. At present, spinal degenerative diseases caused by body degeneration have become the most common type. With the continuous deepening of the research on spinal degenerative diseases and the continuous development, update and promotion of minimally invasive surgery technology and instruments, minimally invasive surgery has attracted more and more attention of spine surgeons due to its advantages of rapid recovery, small trauma and fewer complications.

The core of endoscopic spinal surgery is nerve root decompression. The procedure is centered on the nerve roots, which can be damaged with the slightest carelessness. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Most of the injuries include the stimulation and edema of the nerve root during the operation, which may lead to postoperative sensory retardation and motor weakness, which will damage the patient's physical function and reduce overall satisfaction. The intraoperative nerve exploration is time-consuming and critical, and the variability of the patient's nerve anatomy will also add difficulties to the operation. A real-time auxiliary intraoperative nerve identification technology is necessary.

With the progress of optical technology, fluorescent-guided surgery has shown considerable prospects in assisting in identifying nerves. Indocyanine green (ICG) is the only fluorophore approved by the US Food and Drug Administration (FDA) for intraoperative near-infrared imaging. It can emit near-infrared light after being irradiated by excitation light, which has the characteristics of high penetration depth, low spontaneous fluorescence and high sensitivity. At present, ICG near-infrared fluorescence imaging has been applied to tumor detection, lymphangiography and vascular perfusion evaluation. In recent years, more and more researchers have paid attention to the application value of ICG fluorescence imaging in neuroimaging. It has been applied to clinical research of thoracic sympathetic ganglion, facial nerve, phrenic nerve and pelvic nerve.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430062
        • Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with lumbar disc herniation based on symptoms and Imaging examination
  • Patients undergo endoscopy spinal surgery for nerve root decompression
  • Patients have no clear contraindications to surgery, and has the ability to understand and act and has informed consent, and can participate in all study follow-up voluntarily and signe a written informed consent form.

Exclusion Criteria:

  • The patients have thyroid related diseases, including autonomous nodules
  • Patients are allergic to iodine or shellfish
  • Patients have ankylosing spondylitis, lumbar instability or bony spinal stenosis
  • Patients have diabetes, vascular related diseases, or abnormal liver and kidney function
  • Difficulty in tolerating anaesthesia
  • Pregnant or lactating women
  • Patients are unable to communicate or do not follow directions
  • The investigators consider the patient unsuitable to participate in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Standard endoscopic spinal surgery
Experimental: 0.5mg/kg ICG group
The patients receive 0.5mg/kg ICG intravenous injection before surgery. The search for lumbar nerve roots is performed with the assistance of fluoroscopic endoscopic imaging equipment. And the procedure follows standard endoscopic spinal surgery procedures.
Preoperatively, a single dose of intravenous indocyanine green is administered
Other Names:
  • ICG
Use of a spinal endoscopic fluorescent imaging system to assist surgeons in identifying and protecting nerve roots intraoperatively
Experimental: 1mg/kg ICG group
The patients receive 1mg/kg ICG intravenous injection before surgery. The search for lumbar nerve roots is performed with the assistance of fluoroscopic endoscopic imaging equipment. And the procedure follows standard endoscopic spinal surgery procedures.
Preoperatively, a single dose of intravenous indocyanine green is administered
Other Names:
  • ICG
Use of a spinal endoscopic fluorescent imaging system to assist surgeons in identifying and protecting nerve roots intraoperatively
Experimental: 2mg/kg ICG group
The patients receive 2mg/kg ICG intravenous injection before surgery. The search for lumbar nerve roots is performed with the assistance of fluoroscopic endoscopic imaging equipment. And the procedure follows standard endoscopic spinal surgery procedures.
Preoperatively, a single dose of intravenous indocyanine green is administered
Other Names:
  • ICG
Use of a spinal endoscopic fluorescent imaging system to assist surgeons in identifying and protecting nerve roots intraoperatively

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fluorescence imaging rate of nerve roots
Time Frame: Intraoperative
Number of the nerve roots with fluorescent imaging in the experimental group/Total nerve roots in the experimental group×100%
Intraoperative
Fluorescence signal ratio of nerve root to back fluorescence
Time Frame: Immediately postoperative
Nerve root fluorescence intensity/Background fluorescence intensity
Immediately postoperative
Time taken to find the nerve root endoscopically
Time Frame: Intraoperative
Time from opening the ligamentum flavum to finding the nerve root in spinal endoscopic procedures
Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ICG-related adverse reactions
Time Frame: Immediately after ICG administration to 30 min after administration
Immediately after ICG administration to 30 min after administration
Visual analogue pain scale (Visual analogue scale, VAS)
Time Frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery
The VAS pain score uses the VAS scale, with end 0 being no pain, graded 1-4 being mild pain, 5-6 being moderate pain, 7-9 being severe pain, and end 10 being unbearable pain. The higher the score, the more severe the pain level.
1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery
Oswestry disability index(ODI)
Time Frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery
The ODI score is based on the Oswestry Disability Index questionnaire. The lowest score was 0% and the highest score was 100%, with higher scores indicating more severe functional impairment.
1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery
Surgical complications
Time Frame: Within 1 week after surgery
Record any surgical complications that occurred in the patient within 1 week after surgery
Within 1 week after surgery
Length of surgery
Time Frame: From the beginning to the end of the surgery
Use a timer to record the length of the surgery (accurate to the minute)
From the beginning to the end of the surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuanlong Xie, M.D., Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2023

Primary Completion (Actual)

December 14, 2025

Study Completion (Actual)

December 14, 2025

Study Registration Dates

First Submitted

March 16, 2023

First Submitted That Met QC Criteria

March 29, 2023

First Posted (Actual)

April 11, 2023

Study Record Updates

Last Update Posted (Actual)

December 19, 2025

Last Update Submitted That Met QC Criteria

December 14, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disc Herniation

Clinical Trials on Indocyanine Green

Subscribe